PH12015500248A1
(en )
2018-06-25
Humanized anti-cxcr5 antibodies, derivatives thereof and their uses
RS54795B1
(en )
2016-10-31
Anti-her3 antibodies and uses thereof
NZ599516A
(en )
2013-11-29
Antibodies binding preferentially human csf1r extracellular domain 4 and their use
NZ599628A
(en )
2013-11-29
Axl antibodies
NZ700891A
(en )
2017-05-26
4-1bb binding molecules
MX2010005888A
(en )
2010-06-22
Bivalent, bispecific antibodies.
UA100874C2
(en )
2013-02-11
Bivalent bispecific antibodies
MX2010006396A
(en )
2010-07-05
Bivalent, bispecific antibodies.
MX2010005682A
(en )
2010-06-22
Bivalent, bispecific antibodies.
GEP20156390B
(en )
2015-11-10
Antibody targeting through a modular recognition domain
EP4324480A3
(en )
2024-05-08
Anti-transferrin receptor antibodies and methods of use
UA111818C2
(en )
2016-06-24
ANTIBODY AGAINST CSF-1R
NZ602115A
(en )
2014-12-24
Optimized monoclonal antibodies against tissue factor pathway inhibitor (tfpi)
NZ586754A
(en )
2012-08-31
Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof
MX2009008104A
(en )
2009-08-07
Hepcidin, hepcidin antagonists and methods of use.
MX2011011825A
(en )
2011-12-06
Humanized axl antibodies.
NZ607588A
(en )
2014-02-28
Antibodies against human TWEAK and uses thereof
NZ600470A
(en )
2015-02-27
Anti-c4.4a antibodies and uses thereof
WO2012156532A8
(en )
2014-07-17
Anti-human-her3 antibodies and uses thereof
MX340555B
(en )
2016-07-14
Antibodies against il-18r1 and uses thereof.
NZ616382A
(en )
2015-04-24
Antibodies specific to cadherin-17
NZ629553A
(en )
2016-10-28
Anti-big-endothelin-1 (big-et-1) antibodies and uses thereof
PL1987357T3
(en )
2011-06-30
Polypeptides recognized by anti-trichinella antibodies, and uses thereof
MX2012011829A
(en )
2012-12-17
Anti-polyubiquitin antibodies and methods of use.
AU2008357729A8
(en )
2011-02-03
Antibodies against extracellular domain 2 and 3 of HER2